No Data
No Data
shanghai sanyou medical co., ltd (688085.SH) Supervisor Fang Ying received a warning letter from the Shanghai Securities Regulatory Bureau.
shanghai sanyou medical co., ltd (688085.SH) announced that Ms. Fang Ying, a company supervisor, recently received a notice issued by the Shanghai Securities Regulatory Bureau...
2024 Semi-Annual Report
2024 Semi-Annual Report Summary
Shanghai Sanyou Medical Co., Ltd. (688085.SH) released its semi-annual performance, with a net income of 1.68 million yuan, a year-on-year decrease of 97.34%.
shanghai sanyou medical co., ltd (688085.SH) disclosed the 2024 interim report, during the reporting period, the company achieved revenue of 2.12...
Shanghai Sanyou Medical Co., Ltd. (688085.SH): The net income for the first half of the year was 1.6761 million yuan, a year-on-year decrease of 97.34%.
Shanghai Sanyou Medical Co., Ltd. (688085.SH) announced its semi-annual report for 2024, with operating revenue of 0.212 billion yuan, a year-on-year decrease of 24.86%; net income attributable to shareholders of listed companies was 1.6761 million yuan, a year-on-year decrease of 97.34%; basic earnings per share was 0.01 yuan.
Shanghai Sanyou Medical Co., Ltd (688085.SH): intends to directly and indirectly acquire the remaining 48.1846% equity of Shuimu Tianpeng.
Shanghai Sanyou Medical Co., Ltd. (688085.SH) announced on August 14 that it plans to purchase 37.1077% equity of Shuimu Tianpeng held by Cao Qun and Xu Nong by issuing shares and paying cash, and to purchase 98.9986% LP contribution of Shanghai Huanzhan held by Zhan Songtao, Li Chunyuan, Hu Xiaogang, Wang Xiaoling, Feng Zhen, Dai Zhiling, Liu Qingming, Xu Nong, Yue Zhiyong, Shao Huajiang, and Lv Qinying, through a wholly-owned subsidiary TOTEMS Suzhou by paying cash. It also plans to purchase 1.0014% GP contribution of Shanghai Huanzhan held by Tianpeng Investment through TOTEMS Suzhou by paying cash, and issue shares to no more than 35 specific investors to raise matching funds.
No Data
No Data